Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Bros. Advisors (gp) Llc
Relationship:  
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   16    
Direct Shares   608,718    

Indirect Shares

   158,658,441      
Direct Value   $39,607,747    

Indirect Value

   $12,676,146,062      
Total Shares   159,267,159      
Total Value   $12,715,753,809      


Incyte Corp $28,938,888 Synageva BioPharma Corp $0 Mirati Therapeutics, Inc. $16,084 Seagen Inc $10,649,448 Neurogene $3,327 Incyte Corp $28,938,888 Synageva BioPharma Corp $0 Mirati Therapeutics, Inc. $16,084 Seagen Inc $10,649,448 Neurogene $3,327
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -76.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Genomic Health Inc GHDX Director, 10% Owner 2013-07-01 0 2019-02-27 9,235,362    Premium*  
            Acadia Pharmaceuticals Inc ACAD Director, 10% Owner 2014-03-05 0 2016-04-01 41,897,946    Premium*  
            Incyte Corp INCY Director, 10% Owner 2021-05-14 559,963 2021-05-14 29,367,926    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2014-05-22 0 2014-05-22 518,849    Premium*  
            Aceragen, Inc ACGN Director 2014-07-01 0 2016-01-04 78,885    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-01-07 1,020 2015-01-07 11,877,394    Premium*  
            Mirati Therapeutics, Inc. MRTX 10% Owner 2016-06-09 274 2016-06-09 30,003    Premium*  
            Intellia Therapeutics, Inc. NTLA Former 10% owner 2016-05-11 0 2016-05-11 976,214    Premium*  
            Invitae Corp NVTA 10% Owner 2016-11-17 0 2016-11-17 6,554,039    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 2017-03-24 0 2023-11-22 2,168,818    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2023-05-31 46,557 2023-05-31 42,977,301    Premium*  
            Neurogene NGNE Director, 10% Owner 2023-10-05 904 2023-10-05 1,658,190    Premium*  
            Entrada Therapeutics, Inc. TRDA 10% Owner 2022-05-16 0 2022-06-06 4,501,658    Premium*  
            Atreca Inc BCEL Former 10% Owner 2023-10-19 0 2023-10-19 2,971,128    Premium*  
            Igm Biosciences, Inc. IGMS 2023-12-13 0 2024-03-29 3,755,474    Premium*  
            Vtv Therapeutics Inc. VTVT 2024-03-05 0 2024-03-05 89,254    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
IGMS Igm Biosciences, Inc.   –       •       •   2024-03-29 4 A $0.00 $0 I/I 3,988 3,755,474 0 -
IGMS Igm Biosciences, Inc.   –       •       •   2024-03-28 4 B $9.62 $937,632 I/I 97,473 3,753,480 0.01 -
IGMS Igm Biosciences, Inc.   –       •       •   2024-03-27 4 B $9.22 $257,170 I/I 27,844 3,664,073 0.01 -
IGMS Igm Biosciences, Inc.   –       •       •   2024-03-26 4 B $8.26 $2,230,767 I/I 270,000 3,638,533 0.01 -
VTVT Vtv Therapeutics Inc.   –       •      –    2024-03-05 4 D $0.00 $0 I/I (57,657) 89,254 0 -
VTVT Vtv Therapeutics Inc.   –       •      –    2024-02-27 3 IO $0.00 $0 I/I 0 154,971 -
IGMS Igm Biosciences, Inc.   –       •       •   2023-12-29 4 A $0.00 $0 I/I 1,108 3,390,877 0 -
IGMS Igm Biosciences, Inc.   –       •       •   2023-12-15 4 B $6.36 $1,887,531 I/I 288,007 3,390,323 0.01 -
IGMS Igm Biosciences, Inc.   –       •       •   2023-12-14 4 B $6.50 $1,023,157 I/I 157,370 3,123,585 0.01 -
IGMS Igm Biosciences, Inc.   –       •       •   2023-12-13 4 B $5.76 $520,776 I/I 87,316 2,977,836 0.01 -
BLCM Bellicum Pharmaceuticals,... 10% Owner   –       –       •   2023-11-22 4 OE $0.00 $212 I/I 2,116,349 2,168,818 0 -
BCEL Atreca Inc Former 10% Owner   –       –      –    2023-10-19 4 S $0.40 $110,582 I/I (274,739) 2,971,128 0 %
NGNE Neurogene Director   –       •       •   2023-10-05 4 OE $0.00 $0 I/I 592,650 1,658,190 0 -
NGNE Neurogene Director   –       •       •   2023-08-17 4 B $0.69 $115,617 I/I 166,942 5,612,949 2.25 -
NGNE Neurogene Director   –       •       •   2023-08-16 4 B $0.68 $156,254 I/I 229,600 5,458,724 2.25 -
NGNE Neurogene Director   –       •       •   2023-08-15 4 B $0.63 $1,191,616 I/I 1,888,800 5,246,614 2.25 -
SGEN Seagen Inc Director   –       •       •   2023-05-31 4 A $0.00 $0 I/I 4,088 42,977,301 0 -
BLCM Bellicum Pharmaceuticals,... 10% Owner   –       –       •   2023-05-05 3 IO $0.00 $0 I/I 0 249,123 %
SGEN Seagen Inc Director   –       •       •   2023-05-02 4 GD $0.00 $0 D/D 418,350 23,277 0 -
SGEN Seagen Inc Director   –       •       •   2023-05-01 4 A $0.00 $0 D/D 418,350 232,452 0 -
SGEN Seagen Inc Director   –       •       •   2023-05-01 4 D $0.00 $0 I/I (2,368,357) 1,729,158 0 -
SGEN Seagen Inc Director   –       •       •   2023-05-01 4 OE $36.70 $642,250 I/I 17,500 42,975,257 0 -
TRDA Entrada Therapeutics, Inc... 10% Owner   –       –       •   2022-06-06 4 B $6.35 $245,377 I/I 38,304 4,501,658 1.5 -
TRDA Entrada Therapeutics, Inc... 10% Owner   –       –       •   2022-06-02 4 B $5.82 $15,383 I/I 2,643 4,467,393 1.5 -
TRDA Entrada Therapeutics, Inc... 10% Owner   –       –       •   2022-05-24 4 B $5.74 $137,100 I/I 23,823 4,465,029 1.5 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us